BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26005976)

  • 1. Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?
    Busato WF; Almeida GL; Geraldo J; Busato FS
    Int Braz J Urol; 2015; 41(2):329-36. PubMed ID: 26005976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
    Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial.
    Eggener SE; Large MC; Gerber GS; Pettus J; Yossepowitch O; Smith ND; Kundu S; Kunnavakkam R; Zorn K; Raman JD
    BJU Int; 2013 Nov; 112(7):925-9. PubMed ID: 23890317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients.
    Serretta V; Catanese A; Daricello G; Liotta R; Allegro R; Martorana A; Aragona F; Melloni D
    Prostate Cancer Prostatic Dis; 2008; 11(2):148-52. PubMed ID: 17637759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study.
    Bulbul MA; Wazzan W; Hijaz A; Shaar A
    J Med Liban; 2002; 50(1-2):23-5. PubMed ID: 12841309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.
    Lazzeri M; Abrate A; Lughezzani G; Gadda GM; Freschi M; Mistretta F; Lista G; Fossati N; Larcher A; Kinzikeeva E; Buffi N; Dell'Acqua V; Bini V; Montorsi F; Guazzoni G
    Urology; 2014 Mar; 83(3):606-12. PubMed ID: 24315305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
    Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
    Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA.
    Heldwein FL; Teloken PE; Hartmann AA; Rhoden EL; Teloken C
    BJU Int; 2011 May; 107(10):1576-81. PubMed ID: 21244610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions?
    Torky M; Mosharafa A; Emran A; Kamal A; Abdelhamid M
    Urol Int; 2011; 87(4):416-9. PubMed ID: 21934292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: a prospective randomized controlled trial.
    Ugurlu O; Yaris M; Oztekin CV; Kosan TM; Adsan O; Cetinkaya M
    Urol Int; 2010; 84(2):185-90. PubMed ID: 20215823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA levels of 4.0 - 10 ng/mL and negative digital rectal examination. Antibiotic therapy versus immediate prostate biopsy.
    Shtricker A; Shefi S; Ringel A; Gillon G
    Int Braz J Urol; 2009; 35(5):551-5; discussion 555-8. PubMed ID: 19860933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impacts of antibiotic and anti-inflammatory therapy on serum prostate specific antigen in asymptomatic men: our experience].
    Del Rosso A; Saldutto P; Di Pierro ED; Masciovecchio S; Galatioto GP; Vicentini C
    Urologia; 2012 Dec; 79 Suppl 19():37-40. PubMed ID: 22729607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections.
    Lorente JA; Arango O; Bielsa O; Cortadellas R; Gelabert-Mas A
    Int J Biol Markers; 2002; 17(2):84-9. PubMed ID: 12113586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does antibiotherapy prevent unnecessary prostate biopsies in patients with high PSA values?].
    Faydaci G; Eryildirim B; Tarhan F; Goktas C; Tosun C; Kuyumcuoglu U
    Actas Urol Esp; 2012 Apr; 36(4):234-8. PubMed ID: 22258038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six Weeks of Fluoroquinolone Antibiotic Therapy for Patients With Elevated Serum Prostate-specific Antigen Is Not Clinically Beneficial: A Randomized Controlled Clinical Trial.
    Greiman A; Shah J; Bhavsar R; Armeson K; Caulder S; Jones R; Keane TE; Clarke HS; Savage SJ
    Urology; 2016 Apr; 90():32-7. PubMed ID: 26802800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.
    Stimac G; Reljic A; Spajic B; Dimanovski J; Ruzic B; Ulamec M; Sonicki Z; Kraus O
    Scott Med J; 2009 Aug; 54(3):8-12. PubMed ID: 19725275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.